COMMON SHARE PURCHASE WARRANTS Sample Clauses

COMMON SHARE PURCHASE WARRANTS. THIS IS TO CERTIFY THAT for value received • (the “Holder”) is the registered holder of the number of warrants (the “Warrants”) stated above and is entitled, for each Warrant represented hereby, to purchase one Common Share (subject to adjustment as hereinafter referred to) in the capital of Titan Medical Inc. (the “Company”) at any time from the date of issue hereof up to and including 5:00 p.m. (Toronto Time) on June 29, 2022 (the “Expiry Time”) by surrendering to Computershare Trust Company of Canada (the “Warrant Agent”) at its principal transfer office in Toronto, Ontario this Warrant Certificate with a subscription in the form of the attached Subscription Form duly completed and executed and accompanied by payment of CDN$0.20 per share, subject to adjustment as hereinafter referred to (the “Exercise Price”) by certified cheque, money order or bank draft in lawful money of Canada payable to or to the order of the Company at par in Xxxxxxx, Xxxxxxx. The Holder may purchase less than the number of Common Shares which the Holder is entitled to purchase on the exercise of the Warrants represented by this Warrant Certificate, in which event a new Warrant Certificate representing the Warrants not then exercised will be issued to the holder. The Warrants represented by this Warrant Certificate shall be deemed to have been surrendered and payment by certified cheque, money order or bank draft shall be deemed to have been made, only upon personal delivery thereof or, if sent by post or other means of transmission, upon actual receipt thereof by the Warrant Agent at the office specified above. This Warrant Certificate represents Warrants issued under the provisions of the Warrant Indenture (which indenture together with all other instruments supplemental or ancillary there is referred to herein as the “Warrant Indenture”) dated as of June 29, 2017 between the Company and the Warrant Agent, which contains particulars of the rights of the holders of the Warrants and the Company and of the Warrant Agent in respect thereof and the terms and conditions upon which the Warrants are issued and held, all to the same effect as if the provisions of the Warrant Indenture were herein set forth, to all of which the holder of this Warrant Certificate by acceptance hereof assents. A copy of the Warrant Indenture is available for inspection on the Company’s profile on xxx.xxxxx.xxx or the Company shall, on the written request of the Holder and without charge, provide the Holder...
Sample 1See All (6)
AutoNDA by SimpleDocs
COMMON SHARE PURCHASE WARRANTS. A" ---------------------------------- ENTREE GOLD INC. (the "Company") This certificate (the "Warrant Certificate") is to certify that, for value received, KENNECOTT CANADA EXPLORATION INC. (the "Warrant Holder") is the holder of 5,665,730 common share purchase warrants "A" (the "Warrants") of the Company. For each TWO (2) Warrants, the Warrant Holder has the right to purchase from the Company, upon and subject to the terms and conditions hereinafter referred to, ONE (1) common share without par value (individually, a "Share" and collectively, the "Shares") in the capital of the Company. The Shares may be purchased hereunder at a price of $2.75 (Canadian) per Share unless otherwise adjusted pursuant to the terms hereof (the "Exercise Price"), at any time up to 5:00 p.m. local time in Vancouver, British Columbia on June 29, 2007. The right to purchase the Shares may be exercised in whole or in part, by the Warrant Holder only, at the Exercise Price within the times set forth above by:
Sample 1
COMMON SHARE PURCHASE WARRANTS. Each Warrant will entitle the holder thereof to purchase one additional common share in the capital of the Corporation (a “Warrant Share”) at an exercise price of $0.50 per Warrant Share to the extent such Warrant is exercised on or before the date that is 24 months from the Closing Date (as hereinafter defined). In the event that after four months and one day after the Closing Date, the closing price of the Corporation's common shares on the TSX Venture Exchange (or such other stock exchange on which the Corporation's shares are listed and where a majority of the trading volume occurs), for a period of ten (10) consecutive trading days equals or exceeds $0.75 per common share, the Corporation may, within five (5) days after such an event, provide notice to the warrant holders of early expiry of the Warrants held by each warrant holder and thereafter, such Warrants will expire at 3:30 p.m. (Toronto time) on the date which is twenty-one (21) days after the date of the notice to the warrant holders. ISSUE PRICE: CDN$0.30 per Unit. SIZE OF THE OFFERING: Up to an aggregate of $3,000,000. FINANCIAL ADVISORY AGREEMENT: In the event the Offering is successfully completed raising not less than $2,500,000 in aggregate gross proceeds, the Agent, the Corporation, and Canaccord agree to enter into a mutually acceptable financial advisory agreement (the "Advisory Agreement") whereby the Agent and Canaccord will act, for a period of 24-months following the Closing Date, as a financial advisor to the Corporation. The terms of the Advisory Agreement will be negotiated in good faith between the parties prior to the Closing Date.
Sample 1
COMMON SHARE PURCHASE WARRANTS. Each whole Warrant will entitle the holder to acquire one Share from the Company at a price of US$12.60 per Share for a period of 36 months following Closing.
Sample 1
COMMON SHARE PURCHASE WARRANTS. Each Common Share Purchase Warrant will entitle the holder to buy one Common Share at the exercise price of $0.60 during the first year from completion of the financing, $0.80 during the second year and at an exercise price of $1.00 during the third year. The three year term of the warrants is conditional upon Rockwell achieving Tier 1 status on the TSX Venture Exchange within the first two years. Type of Transaction: “Best Efforts” offering by way of private placement subject to the terms and conditions of the agency agreement. The offering is subject to the private placement requirements of the provinces of Ontario, Alberta and British Columbia, including completion of appropriate forms and private placement commitment letters. The Units may be sold in the United States by private placement and will be available for re-sale under Rule 904 of Regulation S or Rule 144 of the United States Securities Act of 1933. Offering Price: $0.50 per Unit.
Sample 1
COMMON SHARE PURCHASE WARRANTS. The Company has 45,005,805 common share purchase warrants outstanding, each exercisable for one Common Share, as follows: Number Granted Exercise Price ($) Expiry Date 8,333,334 0.05 December 6, 2021 84,000 0.05 December 6, 2021 31,369,224 0.08 February 28, 2022 461,538 0.08 February 28, 2022 4,613,527 0.35 May 20, 2022 144,182 0.35 May 20, 2022 45,005,805 SCHEDULE “B” COMPLIANCE WITH UNITED STATES SECURITIES LAWS This is Schedule “B” to the agency agreement dated as of September 30, 2020 between the Company and the Agent. Capitalized terms used herein and not defined herein shall have the meanings ascribed thereto in the Agency Agreement to which this Schedule “B” is annexed. The following terms shall have the meanings indicated:
Sample 1

Related to COMMON SHARE PURCHASE WARRANTS

  • Purchase Warrants The Company hereby agrees to issue and sell to the Representative (and/or its designees) on the Closing Date an option (“Representative’s Warrant”) for the purchase of an aggregate of [●] shares of Common Stock, representing 5% of the sum of (i) the number of shares of Common Stock contained in the Class A Units sold in this offering and (ii) the number of shares of Common Stock issuable upon conversion of the Preferred Stock contained in the Class B Units sold in this offering, if any, but excluding shares of Common Stock underlying the Warrants issued in this offering and shares of Common Stock (and shares of Common Stock underlying any Warrants) sold, if any, upon exercise of the underwriter’s Over-allotment Option, for an aggregate purchase price of $[ ]. The Representative’s Warrant agreement, in the form attached hereto as Exhibit A (the “Representative’s Warrant Agreement”), shall be exercisable, in whole or in part, commencing on a date which is one (1) year after the Effective Date and expiring on the five-year anniversary of the Effective Date at an initial exercise price per share of Common Stock of $[●], which is equal to 125% of the initial public offering price of the Class A Units sold in this offering. The Representative’s Warrant Agreement and the shares of Common Stock issuable upon exercise thereof are hereinafter referred to together as the “Representative’s Securities.” The Representative understands and agrees that there are significant restrictions pursuant to FINRA Rule 5110 against transferring the Representative’s Warrant Agreement and the underlying shares of Common Stock during the one hundred eighty (180) days after the Effective Date and by its acceptance thereof shall agree that it will not sell, transfer, assign, pledge or hypothecate the Representative’s Warrant Agreement, or any portion thereof, or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition of such securities for a period of one hundred eighty (180) days following the Effective Date to anyone other than (i) an Underwriter or a selected dealer in connection with the Offering, or (ii) a bona fide officer or partner of the Representative or of any such Underwriter or selected dealer; and only if any such transferee agrees to the foregoing lock-up restrictions.

  • Purchase Warrant THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of _________ (“Holder”), as registered owner of this Purchase Warrant, to Aytu BioScience, Inc., a Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from [________________] [DATE THAT IS ONE YEAR FROM THE EFFECTIVE DATE OF THE OFFERING] (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [____________] [DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE OFFERING] (the ”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [____] shares of common stock of the Company, par value $0.0001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[___] per Share [125% of the price of the Shares sold in the Offering]; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

  • Common Shares 4 Company...................................................................................... 4

  • Substitute Purchase Warrant In case of any consolidation of the Company with, or share reconstruction or amalgamation of the Company with or into, another corporation (other than a consolidation or share reconstruction or amalgamation which does not result in any reclassification or change of the outstanding Shares), the corporation formed by such consolidation or share reconstruction or amalgamation shall execute and deliver to the Holder a supplemental Purchase Warrant providing that the holder of each Purchase Warrant then outstanding or to be outstanding shall have the right thereafter (until the stated expiration of such Purchase Warrant) to receive, upon exercise of such Purchase Warrant, the kind and amount of shares of stock and other securities and property receivable upon such consolidation or share reconstruction or amalgamation, by a holder of the number of Shares of the Company for which such Purchase Warrant might have been exercised immediately prior to such consolidation, share reconstruction or amalgamation, sale or transfer. Such supplemental Purchase Warrant shall provide for adjustments which shall be identical to the adjustments provided for in this Section 6. The above provision of this Section shall similarly apply to successive consolidations or share reconstructions or amalgamations.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!